A potentially life-saving treatment containing venom from one of the world’s deadliest spiders is one step closer to human trials, thanks to a $23 million investment in a Brisbane start-up.
Australia may soon have the jump on cane toads after a not-for-profit was granted an exclusive licence to market an IMB-designed bait for the invasive pests.
We can make biofuels with algae, but can we make them commercially viable? IMB is working towards it – and Siemens, Neste Oil Corp, the Queensland Government and others have joined their quest.
An international team involving University of Queensland researchers has used advanced genome sequencing to diagnose 30 patients with unresolved rare diseases.
UQ’s Community for Open Antimicrobial Drug Discovery (CO-ADD) has signed a Memorandum of Understanding (MOU) with the African Network for Drugs and Diagnostics Innovation (ANDI) which is hosted by the United Nations Office for Project Services (UNOPS).
